<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T09:23:21Z</responseDate>
  <request identifier="oai:figshare.com:article/33287076" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33287076</identifier>
        <datestamp>2026-09-21T09:24:49Z</datestamp>
        <setSpec>category_24553</setSpec>
        <setSpec>portal_886</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>supporting data for "CRISPR-based functional screening identifies &lt;i&gt;ITGAV&lt;/i&gt; as a therapeutic target for 5-fluorouracil resistance in colorectal cancer"</dc:title>
          <dc:creator>Jiaxi Li (13134090)</dc:creator>
          <dc:creator>Chi Chung Foo (9055793)</dc:creator>
          <dc:creator>Lui Ng (9054536)</dc:creator>
          <dc:subject>Surgery</dc:subject>
          <dc:subject>colorectal cancer</dc:subject>
          <dc:subject>chemotherapy</dc:subject>
          <dc:subject>ITGAV</dc:subject>
          <dc:subject>CRISPR screening</dc:subject>
          <dc:subject>chemoresistance-related genes</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;This dataset contains raw and processed experimental data investigating the role of integrin subunit alpha V (ITGAV) in colorectal cancer progression and resistance to 5-fluorouracil (5-FU). The data support a research project that combines CRISPR screening, public gene-expression dataset analysis, clinical sample analysis, quantitative PCR, Western blotting, immunohistochemistry, cell proliferation and colony-formation assays, wound-healing and migration assays, flow-cytometric apoptosis analysis, drug-response and combination-index analyses, and in vivo tumor models, including a patient-derived xenograft model. The study evaluates ITGAV expression and function in colorectal cancer cells and 5-FU-resistant derivatives and investigates whether ITGAV knockdown or pharmacological inhibition with cilengitide can improve cellular responses to 5-FU. The deposited files include spreadsheet data, GraphPad Prism analysis files, flow-cytometry data, statistical reports, an R analysis script, and supporting figure materials. Collectively, these data provide experimental evidence for understanding the association between ITGAV and 5-FU resistance and for evaluating ITGAV as a potential therapeutic target in colorectal cancer.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T09:24:49Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.25442/hku.33287076.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/supporting_data_for_CRISPR-based_functional_screening_identifies_i_ITGAV_i_as_a_therapeutic_target_for_5-fluorouracil_resistance_in_colorectal_cancer_/33287076</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
          <dc:rights>Open Access after 2029-08-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
